B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer
- 1 February 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (3), 1570-1575
- https://doi.org/10.1158/0008-5472.can-04-3550
Abstract
Using cDNA database mining strategies and real-time quantitative reverse transcription-PCR, we identified B7-H4 as a novel gene that is overexpressed in ovarian and breast cancer tissues when compared with normal tissues. The gene encodes a protein of 282 amino acids with a signal sequence, an immunoglobulin domain, and a COOH-terminal hydrophobic transmembrane domain. Immunohistochemistry experiments show plasma membrane staining in serous ovarian and breast cancer, confirming the tissue specificity and cell surface localization. We have developed a sensitive dual monoclonal antibody sandwich ELISA to analyze the level of B7-H4 protein in >2,500 serum samples, ascites fluids, and tissue lysates. High levels of B7-H4 protein were detected in ovarian cancer tissue lysates when compared with normal tissues. B7-H4 was present at low levels in all sera but showed an elevated level in serum samples from ovarian cancer patients when compared with healthy controls or women with benign gynecologic diseases. The median B7-H4 concentration in endometrioid and serous histotypes was higher than in mucinous histotypes, consistent with results of immunohistochemical staining. The multivariate logistic regression analysis of B7-H4 and CA125 measured in the same sample set resulted in an area under the curve (AUC) of 0.86 for all stages and 0.86 for stage I/II patients, which was significantly higher than the AUC for either marker alone. In early-stage patients, the sensitivity at 97% specificity increased from 52% for CA125 alone to 65% when used in combination with B7-H4. We conclude that B7-H4 is a promising new biomarker for ovarian carcinoma. (Cancer Res 2006; 66(3): 1570-5)Keywords
This publication has 19 references indexed in Scilit:
- B7-H4 overexpression in ovarian tumorsGynecologic Oncology, 2006
- The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformationExperimental Cell Research, 2005
- Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian CarcinomasCancer Research, 2005
- B7-H4 Is Highly Expressed in Ductal and Lobular Breast CancerClinical Cancer Research, 2005
- Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinomaGynecologic Oncology, 2004
- Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survivalCancer, 2004
- Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 FamilyPublished by The American Association of Immunologists ,2003
- B7x: A widely expressed B7 family member that inhibits T cell activationProceedings of the National Academy of Sciences, 2003
- Calculation of the Risk of Ovarian Cancer From Serial CA-125 Values for Preclinical Detection in Postmenopausal WomenJournal of Clinical Oncology, 2003
- Status of Tumor Markers in Ovarian Cancer ScreeningJournal of Clinical Oncology, 2003